Evidence map›Paper›PMID 41057392›Full record

ArticleScientific reports2025

Clustering and time series analyses of hybrid immunity to SARS-COV-2 using data from the BQC19 biobank.

Jean-Frédéric Boulianne, Denis Larocque, Simon Rousseau, Delphine Bosson-Rieutort

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jean-Frédéric BoulianneHEC Montréal, Montréal, Québec, Canada.ORCID http://orcid.org/0009-0009-2717-9614
Denis LarocqueHEC Montréal, Montréal, Québec, Canada.ORCID http://orcid.org/0000-0002-7372-7943
Simon RousseauThe Meakins-Christie Laboratories, Research Institute of the McGill University Health Centre (RI-MUHC), Montreal, QC, Canada.ORCID http://orcid.org/0000-0002-8773-575X
Delphine Bosson-RieutortCentre de Recherche en Santé Publique (CReSP), Montréal, Québec, Canada. delphine.bosson-rieutort@umontreal.ca.ORCID http://orcid.org/0000-0002-5035-6457

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The SARS-CoV-2 pandemic revealed that immunity after infection was temporary, with reinfections occurring. As the pandemic progressed, individuals encountered infection and vaccination in varying sequences and at different time intervals, resulting in heterogeneous patterns of infection, reinfection and vaccination, so-called hybrid immunity. This study analyzed these patterns by grouping individuals based on their infection, reinfection, and vaccination sequences using data from the Biobanque québécoise de la COVID-19 (BQC19). We applied agglomerative and divisive hierarchical clustering on time series representing patients' COVID-19 episodes, using Dynamic Time Warping to compute distances. Their characterization revealed that clusters followed a temporal progression depending on the timing of infection and its positioning across the pandemic waves. On the other hand, reinfections occurred from the fifth wave onward. The most highly vaccinated groups appear to have been infected and consequently reinfected later in the pandemic. Some groups featured a higher proportion of healthcare workers, while for others, the trajectory and their timeframes were decisive. This study highlights the role of vaccination, which is in line with current knowledge. It also shows that, beyond the sequence of events, it is rather their temporality and the delays between them that are of greatest importance. In terms of hybrid immunity, the results of this study suggest that an infection between two vaccines could offer greater immunity.

Indexed as

COVID-19SARS-CoV-2Biological Specimen BanksCluster AnalysisCOVID-19 VaccinesHumansPandemicsReinfectionTime FactorsVaccinationCOVID-19 VaccinesBQC19Cluster analysisCOVID-19ImmunitySARS-CoV-2Time series

Identifiers

PMID41057392
PMCPMC12504541

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.